Shilpa Medicare Limited (SHILPAMED) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.083x

Based on the latest financial reports, Shilpa Medicare Limited (SHILPAMED) has a cash flow conversion efficiency ratio of 0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.01 Billion ≈ $21.76 Million USD) by net assets (Rs24.39 Billion ≈ $263.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SHILPAMED defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Shilpa Medicare Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Shilpa Medicare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shilpa Medicare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shilpa Medicare Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Orient Semiconductor Electronics Ltd TW:2329	0.022x
MasterBrand Inc. NYSE:MBC	0.065x
BrightView Holdings NYSE:BV	0.026x
Ramkrishna Forgings Limited NSE:RKFORGE	-0.002x
Betsson AB ST:BETS-B	0.074x
Faraday Copper Corp. TO:FDY	0.012x
Reit 1 TA:RIT1	0.006x
Diamond Power Infrastructure Limited NSE:DIACABS	0.340x

Annual Cash Flow Conversion Efficiency for Shilpa Medicare Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Shilpa Medicare Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Shilpa Medicare Limited.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs23.64 Billion ≈ $255.63 Million	Rs1.32 Billion ≈ $14.29 Million	0.056x	-26.35%
2024-03-31	Rs18.00 Billion ≈ $194.66 Million	Rs1.37 Billion ≈ $14.78 Million	0.076x	-40.43%
2023-03-31	Rs17.74 Billion ≈ $191.89 Million	Rs2.26 Billion ≈ $24.46 Million	0.127x	+119.59%
2022-03-31	Rs18.11 Billion ≈ $195.87 Million	Rs1.05 Billion ≈ $11.37 Million	0.058x	+81.52%
2021-03-31	Rs14.67 Billion ≈ $158.70 Million	Rs469.28 Million ≈ $5.08 Million	0.032x	-65.85%
2020-03-31	Rs13.21 Billion ≈ $142.91 Million	Rs1.24 Billion ≈ $13.38 Million	0.094x	-24.09%
2019-03-31	Rs11.90 Billion ≈ $128.69 Million	Rs1.47 Billion ≈ $15.87 Million	0.123x	+196.51%
2018-03-31	Rs10.80 Billion ≈ $116.78 Million	Rs449.20 Million ≈ $4.86 Million	0.042x	+1.43%
2017-03-31	Rs9.14 Billion ≈ $98.83 Million	Rs374.77 Million ≈ $4.05 Million	0.041x	-77.31%
2016-03-31	Rs7.12 Billion ≈ $77.01 Million	Rs1.29 Billion ≈ $13.92 Million	0.181x	+47.44%
2015-03-31	Rs5.61 Billion ≈ $60.71 Million	Rs688.06 Million ≈ $7.44 Million	0.123x	-28.87%
2014-03-31	Rs4.06 Billion ≈ $43.96 Million	Rs700.41 Million ≈ $7.57 Million	0.172x	+29.97%
2013-03-31	Rs3.29 Billion ≈ $35.60 Million	Rs436.38 Million ≈ $4.72 Million	0.133x	-30.71%
2012-03-31	Rs2.81 Billion ≈ $30.37 Million	Rs537.36 Million ≈ $5.81 Million	0.191x	+5.31%
2011-03-31	Rs2.35 Billion ≈ $25.36 Million	Rs426.13 Million ≈ $4.61 Million	0.182x	-65.62%
2010-03-31	Rs1.01 Billion ≈ $10.95 Million	Rs535.22 Million ≈ $5.79 Million	0.528x	+4.69%
2009-03-31	Rs589.21 Million ≈ $6.37 Million	Rs297.43 Million ≈ $3.22 Million	0.505x	+307.88%
2008-03-31	Rs560.02 Million ≈ $6.06 Million	Rs69.31 Million ≈ $749.54K	0.124x	-39.79%
2007-03-31	Rs418.09 Million ≈ $4.52 Million	Rs85.93 Million ≈ $929.33K	0.206x	+203.23%
2006-03-31	Rs350.17 Million ≈ $3.79 Million	Rs-69.72 Million ≈ $-753.98K	-0.199x	--

About Shilpa Medicare Limited

NSE:SHILPAMED India Drug Manufacturers - Specialty & Generic

Market Cap

$1.15 Billion

Rs106.71 Billion INR

Market Cap Rank

#8447 Global

#408 in India

Share Price

Rs545.60

Change (1 day)

-4.68%

52-Week Range

Rs267.00 - Rs932.85

All Time High

Rs985.80